|

Fundus autofluorescence imaging useful in AMD
By
Cheryl Guttman
Fort Lauderdale, FL — Fundus autofluorescence (AF) imaging
shows promise as a prognostic tool in patients with both early and
advanced age-related macular degeneration (AMD), according to preliminary
reports presented at the annual meeting of the Association for Research
in Vision and Ophthalmology.
AF imaging uses a confocal scanning laser ophthalmoscope (Heidelberg
Engineering) to detect accumulations of lipofuscin granules in RPE
cells. The technique is being used to characterise the spatial distribution
and intensity of the lipofuscin-derived autofluorescence in vivo.
Preliminary results from ongoing studies suggested certain patterns
of AF in eyes with early AMD might be associated with risks for
progression to geographic atrophy or exudative choroidal neovascularisation,
whereas AF subtypes in eyes with advanced atrophic AMD might be
predictive of geographic atrophy progression rates.
“AF imaging gives information over and above conventional
imaging techniques, such as fundus photography or fluorescence angiography.
It allows visualisation of metabolic changes at the level of the
RPE and identification of areas at high risk for development of
functional loss,” said Frank G Holz MD, Co-ordinator of the
Fundus Autofluorescence in Age-related Macular Degeneration (FAM)
Study Group who is also Head of the Vitreoretinal Service at the
Department of Ophthalmology, University of Heidelberg.
The study of eyes with early stage AMD included 65 patients aged
56 to 86 years who were followed at six-month intervals with AF
images plus a detailed ophthalmological exam which included fundus
photography and ETDRS visual acuity. Eligible eyes had large soft
drusen, visual acuity 20/100 or better, and no previous laser treatment.
The AF images obtained at baseline were categorised by a pattern
of disturbed AF into four groups: eyes with an annular pattern of
increased AF, eyes with confluent patches of increased AF, eyes
with central spots of increased AF, and diffusely increased AF.
AF imaging may help predict AMD
During the follow-up period, which ranged from six to 25 months,
two patients developed geographic atrophy, and both eyes were noted
at baseline to have diffuse increased AF. In addition, two patients
developed an exudative AMD. Both of those eyes exhibited confluent
patches at baseline.
“From these findings we suggest confluent patches may predict
development of the exudative form of AMD and patients with pattern-like
AF may be at risk from geographic atrophy.
“However, our follow-up is relatively short and we will continue
to monitor this group to determine whether this technique truly
has predictive value. Perhaps this might be a useful tool for defining
risk factors for disease progression that could lead patients to
earlier treatment and a better outcome,” said Wilma Einbock
MD, University of Leipzig.
The study of patients with advanced atrophic AMD included 462 eyes
from 277 patients who were classified into eight groups based on
the AF phenotypic patterns in the junctional zone of geographic
atrophy.
Five distinct patterns of AF were identified: none, focal, banded,
patchy homogenous, and diffuse. The diffuse pattern included four
subtypes: reticular, branching, fine granular, and fine granular
with punctate peripheral spots.
At baseline, diffuse branching was the most common AF type (96 eyes),
followed by banded (50 eyes) and fine granular (49 eyes). There
were 26 eyes with no abnormal AF outside of the geographic atrophy
area, while each of the other AF types was present in 15 or fewer
eyes.
A total of 44 eyes were followed for increase in the area of atrophy
over a period of one to five years. During that time, eyes with
banded and focal AF displayed the slowest rate of size progression,
10% per year and 13% per year, respectively, while those with patchy
homogenous AF showed the greatest increase in area of involvement
at 343% per year.
No other group showed such a high annual progression rate. Among
the eyes with diffuse fine granular AF, atrophy spread by about
30% per year, while in eyes with any of the other diffuse subtypes
as well as those with focal AF, the relative annual progression
rates ranged from 16% to 18%.
“Previous studies with AF show it is superior to fundus photography
or angiography for delineating areas of geographic atrophy. In addition,
we have found that eyes with AMD display variability in AF changes
in the junctional zone and that increased AF may precede the development
or spread of GA over time.
“Our current findings suggest some prognostic significance
for predicting vision loss associated with different patterns of
AF. Fundus AF in geography atrophy seems to be very interesting
— not only for monitoring future therapies aimed to slow geographic
atrophy progression, but also for giving prognostic significance,”
said Steffen Schmitz-Valckenberg MD, Department of Ophthalmology,
University of Heidelberg.
He added that among the various AF types, the patchy homogenous
pattern is associated with the presence of the largest areas of
increased AF. As lipofuscin is the fluorophore detected with AF,
it seems to be a reasonable hypothesis that excessive lipofuscin
accumulation might play an important role in the pathogenesis of
RPE cell death in eyes with geographic atrophy related to AMD, said
Dr Schmitz-Valckenberg.
None of the researchers mentioned in this article has any financial
interest in Heidelberg Engineering.
Top |